Antibody Testing in Patients With Neurological and Psychiatric Symptoms


New research may help doctors determine when (and when not) to test for antiglutamate decarboxylase antibodies in patients with neurological disorders and psychiatric symptoms.

Related Videos
Mandy Alhajj, DO, James Dolbow, DO & Neel Fotedar, MD
Jacob Pellinen, MD
Hai Sun, MD, PhD
Hai Sun, MD, PhD
© 2024 MJH Life Sciences

All rights reserved.